Changyu Liu

1.5k total citations
54 papers, 901 citations indexed

About

Changyu Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Changyu Liu has authored 54 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Changyu Liu's work include Bone Metabolism and Diseases (8 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Bone health and treatments (5 papers). Changyu Liu is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Bone health and treatments (5 papers). Changyu Liu collaborates with scholars based in China, Australia and France. Changyu Liu's co-authors include Yongde Liao, Jun Xiao, Cong Cai, Bo Ai, Hanfeng Guan, Libo Zhao, Frank S. Fan, Liming Zhao, Zheng Zhang and Hui Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Changyu Liu

49 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changyu Liu China 17 339 168 150 121 120 54 901
Jun Sun China 17 356 1.1× 161 1.0× 123 0.8× 47 0.4× 98 0.8× 55 853
Yuanqiang Zhang China 23 688 2.0× 149 0.9× 89 0.6× 144 1.2× 109 0.9× 90 1.6k
Chao Xia China 16 213 0.6× 88 0.5× 107 0.7× 129 1.1× 92 0.8× 66 858
Ju Hyun Park South Korea 23 809 2.4× 94 0.6× 105 0.7× 131 1.1× 135 1.1× 91 1.6k
Ting Yan China 19 340 1.0× 308 1.8× 69 0.5× 46 0.4× 106 0.9× 75 1.0k
Zhengdong Li China 17 248 0.7× 105 0.6× 107 0.7× 61 0.5× 57 0.5× 95 892
Yaoyu Chen United States 23 587 1.7× 161 1.0× 82 0.5× 76 0.6× 113 0.9× 59 1.7k
Na Duan China 16 725 2.1× 268 1.6× 75 0.5× 61 0.5× 157 1.3× 64 1.4k

Countries citing papers authored by Changyu Liu

Since Specialization
Citations

This map shows the geographic impact of Changyu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu Liu more than expected).

Fields of papers citing papers by Changyu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu Liu. The network helps show where Changyu Liu may publish in the future.

Co-authorship network of co-authors of Changyu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Changyu Liu. A scholar is included among the top collaborators of Changyu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyu Liu. Changyu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Changyu, et al.. (2024). Neural and immune roles in osteoarthritis pain: Mechanisms and intervention strategies. Journal of Orthopaedic Translation. 48. 123–132. 8 indexed citations
2.
Chen, Huilong, Changyu Liu, Yuan Zhan, et al.. (2024). Alpinetin ameliorates bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation. Biomedicine & Pharmacotherapy. 171. 116101–116101. 7 indexed citations
3.
Zheng, Meng, Yuanli Zhu, Renpeng Peng, et al.. (2023). Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis. International Journal of Molecular Sciences. 24(6). 5355–5355. 15 indexed citations
4.
Wang, Chao, Hai‐Xing Wang, Changyu Liu, et al.. (2023). Conversion of carbon dioxide in atmospheric pressure dielectric barrier discharges with different electrode configurations. Physica Scripta. 98(8). 85605–85605. 3 indexed citations
5.
Chen, Ming, et al.. (2023). Anomaly detection of EEG in patients with epilepsy based on graph deviation network. 198–198. 2 indexed citations
6.
Yao, Yicheng, et al.. (2022). Heart Murmur Detection from Phonocardiogram Based on Residual Neural Network with Classes Distinguished Focal Loss. Computing in cardiology. 49. 1 indexed citations
7.
Liu, Changyu, et al.. (2021). Circular RNA circ_0000517 Facilitates The Growth andMetastasis of Non-Small Cell Lung Cancer by SpongingmiR-326/miR-330-5p. SHILAP Revista de lepidopterología. 6 indexed citations
8.
Liu, Hui, Yuanli Zhu, Yutong Gao, et al.. (2020). NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Cell Death and Disease. 11(2). 129–129. 97 indexed citations
9.
Liu, Hui, Yonghui Dong, Yutong Gao, et al.. (2018). Hesperetin suppresses RANKL‐induced osteoclastogenesis and ameliorates lipopolysaccharide‐induced bone loss. Journal of Cellular Physiology. 234(7). 11009–11022. 38 indexed citations
10.
Cai, Cong, Changyu Liu, Liming Zhao, et al.. (2018). Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo. Frontiers in Pharmacology. 9. 1286–1286. 61 indexed citations
11.
Zhao, Liming, Hanfeng Guan, Chao Song, et al.. (2018). YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism. Bone. 110. 177–186. 51 indexed citations
12.
Fu, Shengling, Changyu Liu, Quanfu Huang, et al.. (2018). Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer. Oncology Reports. 39(3). 1313–1321. 13 indexed citations
13.
Huang, Quanfu, Zheng Zhang, Yongde Liao, et al.. (2018). 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression. Journal of Experimental & Clinical Cancer Research. 37(1). 133–133. 47 indexed citations
14.
Shi, Jia, Zheng‐tao Lv, Weiwei Lu, et al.. (2018). Human nail stem cells are retained but hypofunctional during aging. Journal of Molecular Histology. 49(3). 303–316. 8 indexed citations
15.
Liu, Changyu & Ni Zhang. (2017). Diagnosis and treatment of esophageal tuberculosis. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 16(5). 533–535.
16.
Zhao, Libo, Cong Cai, Jing Wang, et al.. (2017). Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity. Frontiers in Pharmacology. 8. 928–928. 21 indexed citations
17.
Tang, Wenhao, Changyu Liu, Jinliang Zhu, et al.. (2015). Identification and Characterization of Xlr5c as a Novel Nuclear Localization Protein in Mouse Germ Cells. PLoS ONE. 10(6). e0130087–e0130087. 5 indexed citations
18.
Liu, Changyu. (2014). Efficacy Observation of Duodenal Ulcer of Aged People Treated with Huangqi Jianzhong Decoction(Traditional Chinese Medicine Formula Granules) and Rabeprazole. Liaoning zhongyi zazhi. 1 indexed citations
19.
Liu, Changyu, et al.. (2014). Crosstalk between IGF-1R and other Tumor Promoting Pathways. Current Pharmaceutical Design. 20(17). 2912–2921. 38 indexed citations
20.
You, Liangkun, Changyu Liu, Hexiao Tang, Yongde Liao, & Shengling Fu. (2014). Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment. Current Pharmaceutical Design. 20(17). 2899–2911. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026